[Immunotherapeutic studies on EN-L2C guinea pig leukemia].
Miyamoto
M
M
D000818:Animals; D001500:BCG Vaccine / Q000627:therapeutic use*; D001921:Brain / Q000528:radiation effects; D002460:Cell Line; D017358:Cell Wall Skeleton; D003131:Combined Modality Therapy; D003520:Cyclophosphamide / Q000627:therapeutic use; D006168:Guinea Pigs; D007945:Leukemia, Lymphoid / Q000276:immunology / Q000532:radiotherapy / Q000628:therapy*; D051379:Mice; D009088:Mucoproteins / Q000627:therapeutic use*; D013116:Spinal Cord / Q000528:radiation effects; D014750:Vincristine / Q000627:therapeutic use
D001500:BCG Vaccine; D017358:Cell Wall Skeleton; D009088:Mucoproteins; C044553:cell wall skeleton, Nocardia; D014750:Vincristine; D003520:Cyclophosphamide